Skip to content

Effect of Qiangxin Recipe on myocardial fibrosis in patients with ischemic heart disease and heart failure: a randomized controlled study

Effect of Qiangxin Recipe on myocardial fibrosis in patients with ischemic heart disease and heart failure: a randomized controlled study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037254
Enrollment
Unknown
Registered
2020-08-27
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart failure

Interventions

Sponsors

Shanghai Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. From January 2021 to June 2023, patients with coronary heart disease complicated with heart failure were diagnosed in the Department of Cardiology and outpatient department of Shanghai Traditional Chinese medicine hospital; 2. At present, the patient is in clinical stage C of heart failure; 3. According to the four diagnostic methods of TCM and syndrome differentiation, it is mainly due to deficiency of heart and kidney yang, and can be combined with phlegm, blood stasis and water stagnation; 4. Older than 18.

Exclusion criteria

Exclusion criteria: 1. Patients with acute coronary syndrome; 2. Acute left and right heart failure; 3. Patients with tumor and multiple organ failure.

Design outcomes

Primary

MeasureTime frame
NT-proBNP;Cardiovascular events;Assessment of myocardial fibrosis;

Secondary

MeasureTime frame
Evaluation of TCM syndrome curative effect;Evaluation of therapeutic effect of angina pectoris symptoms;Quality of life;

Countries

China

Contacts

Public ContactZhang Lei

Shanghai Hospital of Traditional Chinese Medicine

49949745@qq.com+86 18116070362

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026